BioDelivery Sciences International, Inc.
BDSI · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $320,208 | $419,288 | $525,911 | $233,711 |
| - Cash | $114,309 | $111,584 | $63,888 | $43,822 |
| + Debt | $58,792 | $78,452 | $58,568 | $51,652 |
| Enterprise Value | $264,691 | $386,156 | $520,591 | $241,541 |
| Revenue | $166,703 | $156,471 | $111,389 | $55,640 |
| % Growth | 6.5% | 40.5% | 100.2% | – |
| Gross Profit | $143,330 | $131,806 | $89,799 | $39,857 |
| % Margin | 86% | 84.2% | 80.6% | 71.6% |
| EBITDA | $44,542 | $40,495 | $12,567 | -$17,765 |
| % Margin | 26.7% | 25.9% | 11.3% | -31.9% |
| Net Income | $84,860 | $25,711 | -$15,305 | -$33,867 |
| % Margin | 50.9% | 16.4% | -13.7% | -60.9% |
| EPS Diluted | 0.82 | 0.24 | -0.18 | -0.54 |
| % Growth | 241.7% | 233.3% | 66.7% | – |
| Operating Cash Flow | $41,037 | $24,981 | $11,072 | -$24,113 |
| Capital Expenditures | -$415 | -$13 | -$79 | -$2,063 |
| Free Cash Flow | $40,622 | $24,968 | $10,993 | -$26,176 |